BeyondSpring (NASDAQ:BYSI – Get Rating) and Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations. Valuation & Earnings This table compares BeyondSpring and Processa Pharmaceuticals’ […]
Equities analysts predict that Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) will report earnings of ($0.24) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Processa Pharmaceuticals’ earnings. Processa Pharmaceuticals reported earnings per share of ($0.14) during the same quarter last year, which suggests a negative year […]
Wall Street brokerages expect Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) to post earnings per share of ($0.18) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Processa Pharmaceuticals’ earnings. Processa Pharmaceuticals reported earnings of ($0.90) per share in the same quarter last year, which indicates a positive year-over-year […]